Mapping Investment in an Industry
A little while ago we were asked to pull together a map of foreign direct investment in bioprocessing capability made around the globe in the previous decade. We wanted to know how difficult it would be for a region to make a difference to the competitiveness of its bioprocessing industrial capacity and skills and what form that intervention might take.
Using a variety of sources from news feeds, web sites, directories and personal information we pulled together the map that you see at the bottom of this article. It became clear pretty quickly that the scale both of the investments and the associated incentives would dwarf anything that could realistically be offered. In total over that decade at least $12B was invested in new plant with approximately $3.6B of declared incentives. Other incentives in the form of tax reliefs, land/plant deals and competitive corporate tax rates would add significantly to this number over the lifetime of the investment.
The data are interesting to play with, and you may know of deals that we missed or that have happened since we did the analysis. The version in this post is just a static image, but there is an interactive version of the map here
The real map is interactive, so you can subselect bits of the information that you are interested in, e.g. just to show fill and finish facilities for small molecule products or manufacturing sites for vaccine production. Just click on the lists at the bottom (underneath the map) to select the bits you are interested in. Click on a spot on the map to find out a bit more about the investment.
I am in the process of pulling together a more complete map of all biopharmaceutical manufacturing and processing facilities as part of a LinkedIn discussion in the Professionals in Pharmaceutical Industry and Biotech Industry group. The good folks there have identified about 500 sites worldwide, and I’ve said I will map them for them once we have sufficient data, so check back in a while for the updated map.
Bioprocessing manufacturing investments from 1998-2008
